Dollars for Docs

How Industry Dollars Reach Your Doctors

LUCENTIS
drug

LUCENTIS

Treats wet age-related macular degeneration, macular edema caused by a blocked blood vessel in the eye, and diabetic macular edema.
Cash
$0

payments related to this drug

Doctor
3,933

doctors receiving payments

Company
7

companies making payments related to this drug

Drug
2%

of payments for this drug were also associated with another product

Companies Making Payments Related to this Drug

Aggregate totals are shown, including payments to doctors and teaching hospitals. To purchase bulk data, please visit the ProPublica Data Store.

Company Payment
GENENTECH, INC. $64.5M
GENENTECH USA, INC. $7.16M
F. HOFFMANN-LA ROCHE AG $707K
NOVARTIS PHARMA AG $356K
ROCHE TCRC, INC. $29,053
NOVARTIS PHARMACEUTICALS CORPORATION $19,383
HOFFMANN-LA ROCHE LIMITED $8,405

Note: We have made some effort to normalize the data and eliminate duplicates, but data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].